JP2016520120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520120A5 JP2016520120A5 JP2016516287A JP2016516287A JP2016520120A5 JP 2016520120 A5 JP2016520120 A5 JP 2016520120A5 JP 2016516287 A JP2016516287 A JP 2016516287A JP 2016516287 A JP2016516287 A JP 2016516287A JP 2016520120 A5 JP2016520120 A5 JP 2016520120A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- tetrahydro
- isoquinolin
- acetamide
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2013054478 | 2013-05-30 | ||
| IBPCT/IB2013/054478 | 2013-05-30 | ||
| PCT/IB2014/061774 WO2014191929A1 (en) | 2013-05-30 | 2014-05-28 | Cxcr7 receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016520120A JP2016520120A (ja) | 2016-07-11 |
| JP2016520120A5 true JP2016520120A5 (cg-RX-API-DMAC10.html) | 2017-06-29 |
| JP6393749B2 JP6393749B2 (ja) | 2018-09-19 |
Family
ID=50943357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516287A Expired - Fee Related JP6393749B2 (ja) | 2013-05-30 | 2014-05-28 | Cxcr7受容体調節剤 |
Country Status (30)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR091516A1 (es) | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida |
| US10202368B2 (en) | 2014-12-01 | 2019-02-12 | Idorsia Pharmaceuticals Ltd. | CXCR7 receptor modulators |
| US20170112831A1 (en) * | 2015-10-23 | 2017-04-27 | James MERRITT | Use of ccr1 antagonists as a treatment for tumors of the central nervous system |
| EP3490986B1 (en) * | 2016-07-28 | 2021-11-24 | Idorsia Pharmaceuticals Ltd | Piperidine cxcr7 receptor modulators |
| AR111808A1 (es) | 2017-05-18 | 2019-08-21 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina como moduladores del receptor de pge2 |
| EA201992676A1 (ru) | 2017-05-18 | 2020-05-06 | Идорсия Фармасьютиклз Лтд | Фенильные производные в качестве модуляторов pge2 рецепторов |
| KR102502046B1 (ko) | 2018-01-26 | 2023-02-20 | 이도르시아 파마슈티컬스 리미티드 | Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-{[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노}-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896170A (en) | 1969-02-26 | 1975-07-22 | American Home Prod | Intermediates for the preparation of 1,3-dihydro-2h-1, -benzodiazepin-2-ones |
| RU2214405C2 (ru) | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов |
| GB9816984D0 (en) * | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
| US7256201B2 (en) | 2000-12-07 | 2007-08-14 | Astrazeneca Ab | Selective estrogen receptor-β ligands |
| ATE427933T1 (de) | 2002-12-20 | 2009-04-15 | Chemocentryx Inc | Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor |
| ATE486875T1 (de) * | 2005-11-10 | 2010-11-15 | Chemocentryx Inc | Substituierte chinolone und verwendungsverfahren |
| US20100331298A1 (en) | 2007-12-10 | 2010-12-30 | Cytopathfinder, Inc. | Carboxamide Compounds and Their Use |
| AR091516A1 (es) * | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida |
| US10202368B2 (en) | 2014-12-01 | 2019-02-12 | Idorsia Pharmaceuticals Ltd. | CXCR7 receptor modulators |
-
2014
- 2014-05-28 BR BR112015030095-2A patent/BR112015030095B1/pt not_active IP Right Cessation
- 2014-05-28 MY MYPI2015704311A patent/MY173564A/en unknown
- 2014-05-28 CA CA2912133A patent/CA2912133C/en active Active
- 2014-05-28 MX MX2015016429A patent/MX364104B/es active IP Right Grant
- 2014-05-28 EP EP14730591.6A patent/EP3004082B1/en active Active
- 2014-05-28 US US14/892,959 patent/US9920010B2/en not_active Expired - Fee Related
- 2014-05-28 SI SI201430415T patent/SI3004082T1/sl unknown
- 2014-05-28 LT LTEP14730591.6T patent/LT3004082T/lt unknown
- 2014-05-28 PL PL14730591T patent/PL3004082T3/pl unknown
- 2014-05-28 CN CN201480030766.2A patent/CN105263924B/zh not_active Expired - Fee Related
- 2014-05-28 SG SG11201509057UA patent/SG11201509057UA/en unknown
- 2014-05-28 MA MA38679A patent/MA38679B1/fr unknown
- 2014-05-28 WO PCT/IB2014/061774 patent/WO2014191929A1/en not_active Ceased
- 2014-05-28 EA EA201501163A patent/EA028604B1/ru not_active IP Right Cessation
- 2014-05-28 KR KR1020157036801A patent/KR102302580B1/ko not_active Expired - Fee Related
- 2014-05-28 HU HUE14730591A patent/HUE036649T2/hu unknown
- 2014-05-28 NO NO14730591A patent/NO3004082T3/no unknown
- 2014-05-28 ES ES14730591.6T patent/ES2645470T3/es active Active
- 2014-05-28 PT PT147305916T patent/PT3004082T/pt unknown
- 2014-05-28 UA UAA201512741A patent/UA118562C2/uk unknown
- 2014-05-28 DK DK14730591.6T patent/DK3004082T3/en active
- 2014-05-28 JP JP2016516287A patent/JP6393749B2/ja not_active Expired - Fee Related
- 2014-05-28 AU AU2014272718A patent/AU2014272718B2/en not_active Ceased
- 2014-05-28 HR HRP20171597TT patent/HRP20171597T1/hr unknown
- 2014-05-29 TW TW103118884A patent/TWI640510B/zh not_active IP Right Cessation
- 2014-05-29 AR ARP140102121A patent/AR096490A1/es active IP Right Grant
-
2015
- 2015-11-25 IL IL242782A patent/IL242782B/en active IP Right Grant
- 2015-11-26 PH PH12015502632A patent/PH12015502632B1/en unknown
- 2015-11-27 CL CL2015003470A patent/CL2015003470A1/es unknown
-
2017
- 2017-11-02 CY CY20171101149T patent/CY1119537T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10195213B2 (en) | Chemical entities that kill senescent cells for use in treating age-related disease | |
| HRP20171597T1 (hr) | Modulatori cxcr7-receptora | |
| JP2017535618A5 (cg-RX-API-DMAC10.html) | ||
| US8481001B2 (en) | Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer | |
| ES2660317T3 (es) | Combinación de fármacos | |
| JP5490292B2 (ja) | 医学的状態を治療するための方法、組成物、およびキット | |
| JP2016510032A5 (cg-RX-API-DMAC10.html) | ||
| US20080089859A1 (en) | Administration of sleep restorative agents | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| RU2011151277A (ru) | Мостиковые производные спиро[2.4]гептана в качестве агонистов рецептора alx и/или fprl2 | |
| JPH09511739A (ja) | フィブロミアルギアの処置のためのセロトニンアンタゴニスト(5ht▲下3▼)の使用 | |
| JP2021512143A5 (cg-RX-API-DMAC10.html) | ||
| US11666582B2 (en) | Medicament for treating cough | |
| JP2002542287A (ja) | 医 薬 | |
| RU2013108456A (ru) | Пиримидиновые производные, используемые в качестве ингибиторов протеинкиназы | |
| CA2660529A1 (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| RU2007115161A (ru) | Новые производные фталазинона в качестве ингибиторов киназы аврора-а | |
| JPS61134314A (ja) | 獣医薬鎮静鎮痛剤 | |
| RU2008104134A (ru) | Кининовые антагонисты для лечения дисфункции мочевого пузыря | |
| US12576083B2 (en) | Combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer | |
| JP2023509168A (ja) | BTK阻害剤2-[(3R)-3-[4-アミノ-3-(2-フルオロ-4-フェノキシ-フェニル)ピラゾロ[3,4-d]ピリミジン-1-イル]ピペリジン-1-カルボニル]-4-メチル-4-[4-(オキセタン-3-イル)ピペラジン-1-イル]ペンタ-2-エンニトリルを使用する、膜性腎症、IGG4関連疾患、及び抗リン脂質症候群の処置 | |
| JP2023542730A (ja) | スフィンゴシン-1-リン酸受容体アゴニストの使用 | |
| CN1355698A (zh) | 可用作治疗有关支气管收缩的机能障碍的药物的化合物 | |
| US20050043366A1 (en) | Polyamine compounds for treating chemokine receptor mediated diseases | |
| CN1348372A (zh) | 药物用途 |